glp 1 elevated liver enzymes Why are GLP-1 agonists being used to treat patients with nonalcoholic fatty disease? Semaglutide and Its Potential Hepatoprotective

Clinical takeaway: When the pattern doesn't fit classic OA, an early rheumatology evaluation changes outcomes

The practical implication is that if you are having bloodwork done for any purpose, including a physical, insurance medical exam, or pre-surgical workup, semaglutide will have changed your glucose parameters

As you lose weight, your body needs fewer calories to maintain its new, smaller size

These early results come at a critical time for Novo Nordisk, which is under pressure to reinforce its innovation pipeline following underwhelming results from its other next-generation candidate, CagriSema

If you switch to tirzepatide 7 days after your last semaglutide dose, you still have approximately 50% of your semaglutide dose circulating

It helps contextualise how the hottest thing in GLP-1 is not just more % weight loss its why that weight loss connects to so many diseases, and what lies beyond